← FDA Drug Approvals (Drugs@FDA)

CEPHALEXIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2005-08-17

Drug application

FDA Application #

ANDA065234

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEPHALEXIN

Generic name

CEPHALEXIN

Active ingredients

CEPHALEXIN

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

LUPIN

Manufacturer

Lupin Pharmaceuticals, Inc.

First approval

2005-08-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown